Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1981
12/08/1981US4304692 Resin peptide for making calcitonin analogues
12/08/1981CA1113928A1 Somatostatin analogs and intermediates thereto
12/08/1981CA1113859A1 Method for the preparation of chorionic human somatomammotropin
12/02/1981EP0041019A2 Products prepared from the thymic series factor or from its analogues and derivatives, process for preparation thereof, these products for use as medicines, radioactive tracers obtained from these products and use of these radioactive tracers in dosage processes
12/02/1981EP0040728A1 An improvement in and relating to assaying methods involving biospecific affinity reactions
12/02/1981EP0040641A1 Process for isolating and purifying a fraction capable of inhibiting mutagenicity of a mutagenic material from burdock juice
12/01/1981US4303650 Process for production of erythropoietin
12/01/1981US4303649 1-Phenyl-2-aminoethanol derivatives
12/01/1981CA1113458A1 Phenylglycine derivatives
12/01/1981CA1113457A1 Aminoethylglycine containing polypeptides
12/01/1981CA1113412A1 Proteinic active substances
12/01/1981CA1113411A1 Physiologically active substance esterastin and production thereof
11/1981
11/26/1981WO1981003329A1 Oligopeptides with specific inhibiting properties of collagen induced aggregation,process for preparing the same and pharmaceutical compositions containing them
11/25/1981EP0040397A1 Process for the preparation of blood plasma fractions
11/25/1981EP0040240A1 Transplantable sheets of living keratinous tissue
11/24/1981US4302448 Secretin preparations with intensified and protracted action, process for their manufacture, their use as well as dihydroxybenzoyl-L-tyrosine
11/24/1981US4302445 Cold washing the extracted cryoprecipitate
11/24/1981US4302386 Hormones linked to a group causing immune response
11/24/1981US4302385 Placenta-specific tissue protein PP10
11/24/1981CA1113088A1 PROCESS FOR THE PREPARATION OF THYMOSIN .alpha..SUB.1 AND AN ANALOGUE
11/18/1981EP0040149A1 Oligopeptides with specific inhibiting properties of collagen induced aggregation, process for preparing the same and pharmaceutical compositions containing them
11/18/1981EP0039726A1 Method of enzymatic debridement
11/17/1981US4301153 Heparin preparation
11/17/1981US4301151 Long-lasting agonists of enkephalin
11/17/1981US4301144 By coupling to a polyoxyalkylene glycol for increased oxygen carrying capacity
11/17/1981US4301066 Preparation of (D-Trp 6)-LH-RH via the heptapeptide H-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2
11/17/1981US4301065 Novel polypeptides having thymic activity or an antagonistic activity and processes for their synthesis
11/17/1981US4301064 Ubiquitary tissue protein PP8
11/17/1981US4301045 Resin peptides
11/17/1981CA1112639A1 Mono-insulin and method of preparing the same
11/17/1981CA1112570A1 Preparations for vaginal administration
11/17/1981CA1112565A1 Process for concentrating blood coagulation factor xiii derived from human placentae
11/12/1981WO1981003175A1 Carbohydrate derivatives for inhibiting bacterial adherence
11/12/1981WO1981003124A1 Polypeptide fraction from mussel for medical use
11/11/1981EP0039528A1 Process for preparing soya proteins of agreeable taste for human use and product thus obtained
11/10/1981US4299821 Hypothermic agents, treatment of narcolepsy
11/10/1981US4299820 Therapeutic process employing amides of L and DL phenylglycines
11/10/1981US4299763 A-30912B Nucleus
11/10/1981US4299762 A-30912D Nucleus
11/10/1981CA1112164A1 Therapeutic selenium compositions and the use thereof
11/04/1981EP0038935A1 Process for the immunological determination of enzymes, agent for its realization and its use
11/03/1981US4298598 Tissue adhesive
11/03/1981US4298523 Oligopeptides of arginine, lysine, valine, sarcosine, aspartic or glutamic acid, and tyrosine
11/03/1981CA1111841A1 Cyclopeptides
11/03/1981CA1111790A1 L-LYSINE .alpha.-OXIDASE
11/03/1981CA1111765A1 Reductant composition for technetium-99m and method for making technetium-99m labelled ligands
11/03/1981CA1111762A1 Fluorescent rare earth chelate in polymeric latex particles
10/1981
10/29/1981WO1981002977A1 Sterilized,preserved,stable mucine-containing solutions and sterilization method
10/28/1981EP0038667A1 IgM derivatives and process for the preparation thereof
10/28/1981EP0038642A1 A monoclonal antibody against hepatitis B and its production, a hybridoma producing the monoclonal antibody and compositions containing it, the propagation of the hybridoma and the monoclonal antibody for use as an antiviral agent against hepatitus B and in isolating hepatitus b surface antigen from a sample
10/28/1981EP0038511A2 Wound healing compositions
10/28/1981EP0038393A1 Process for recovering enzymes from blood
10/28/1981EP0038357A1 Hydrolytic enzyme-activatible pro-drugs
10/27/1981US4297346 Pseudopeptides used as medicaments
10/27/1981US4297344 Blood coagulation factors and process for their manufacture
10/27/1981US4297343 Contraceptive agent
10/27/1981US4297277 Derivatives of A-30912B nucleus
10/27/1981US4297276 Thymosin beta 3 and beta 4
10/27/1981US4297275 Inhibitors of mammalian collagenase
10/27/1981US4297274 Globulins; immunology
10/27/1981CA1111414A1 L-pyroglutamyl-l-seryl-glycine-glycine amide
10/21/1981EP0038173A2 Artificial red cells and a process for preparing them
10/21/1981EP0038172A2 A process for preparing artificial red cells
10/21/1981EP0038154A1 Allergens modified with polysarcosines
10/21/1981EP0038135A2 LRF antagonists
10/21/1981EP0038132A2 Process for preparing protease inhibitors
10/21/1981EP0038117A1 Methods for preparing anti-hypertensive agents
10/21/1981EP0037963A2 PP9 protein, method of its isolation and its utilisation
10/20/1981US4296125 Derivatives of benzoylphenoxyalkanoic acids having normolipemizing activity
10/20/1981US4296110 Antihypertensive I-substituted cyclic lactam-2-carboxylic acids
10/20/1981US4296100 Administering fibroblast growth factor to increase blood flow in ischemic area
10/20/1981US4296098 Montmorillonite, pyroligneous acid and papain
10/20/1981US4296097 Suppression of reaginic antibodies to drugs employing polyvinyl alcohol as carrier therefor
10/20/1981US4296027 Pure intravenous human and animal gamma globulins
10/20/1981US4296025 Process for preparing human interferon
10/20/1981US4295855 Method for separating fibrinogen and its constituent components
10/20/1981CA1111023A1 Process for recovering purified albumin from blood plasma
10/20/1981CA1110976A1 Cosmetic composition with slimming properties and against cellulitis
10/20/1981CA1110971A1 Collagen skin dressing
10/15/1981WO1981002893A1 Sulfur-containing acylamino acids
10/15/1981WO1981002834A1 Heme concentrate and method for the preparation thereof
10/14/1981EP0037736A1 Mycoplanecin derivatives, their preparation and pharmaceutical compositions containing them
10/14/1981EP0037687A2 Recombinant deoxyribonucleid acid which codes for plasminogen activator and method of making plasminogen activator protein therefrom
10/14/1981EP0037516A1 N-omega substituted derivatives of 1-Desamino-vasopressin analogs
10/13/1981US4294826 Process for the preparation of highly purified antihemophilic factor
10/13/1981US4294825 Separation of the glycoprotein satietin
10/13/1981US4294824 Extracts of the hemopoietic system
10/13/1981US4294754 Ring peptide antibiotics, Permetin A and a process for producing the same
10/13/1981CA1110617A1 Glycoprotein and process for isolating it
10/07/1981EP0037388A2 Pharmaceutical forms, their preparation and compositions containing the same
10/07/1981EP0037319A1 Mucopolysaccharides having biological properties; their preparation and use as medicines
10/07/1981EP0037256A1 Process for producing an insulin
10/07/1981EP0037255A1 Process for producing an insulin precursor
10/07/1981EP0037246A2 Polypeptides
10/07/1981EP0037231A2 Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
10/07/1981EP0037175A1 Pharmaceutical compositions
10/07/1981EP0037144A2 Chromium complexes as dietary supplements and pharmaceutical agents
10/07/1981EP0037127A1 Use of a luteinising peptide as anti-contraceptive
10/07/1981EP0037078A2 Process for heat treatment of aqueous solution containing human blood coagulation factor XIII
10/07/1981EP0037043A1 Stabilised ophthalmic formulation